A major investor is pushing Novartis to improve how it handles buying other companies after recent problems.

NVS · Novartis AG

The AI's read

Novartis reported back-to-back Phase 3 failures and drew investor criticism over past deals and write-downs. A large shareholder is urging a board shake-up and tougher deal oversight. Those facts point toward increased governance and financial pressure on the company.